AND ANSWERS WITH SOLUTIONS 2024
WhichWofWtheWfollowingWstatementsWconcerningWuseWofWPrecedexWinWcriticalWcareWpatientsWisWcorrect?
A
ItWcanWonlyWbeWusedWifWtheWpatientWisWintubated.
B
ItWcanWonlyWbeWusedWifWtheWpatientWisWalsoWreceivingWaWparalytic.
C
ItWwillWdecreaseWbloodWpressure.
D
ItWisWindicatedWforWuseWupWtoW72Whours.
E
ItWisWmoreWlikelyWtoWcauseWdeliriumWthanWaWbenzodiazepine.W-
WANSWERWItWwillWdecreaseWbloodWpressure.
MHWisWaW65WyearWoldWpost-
menopausalWfemaleWwithWaWfamilyWhistoryWofWbreastWcancer.WSheWwasWrecentlyWdiagnosedWwithWosteop
orosisWandWwantsWtoWknowWifWsheWcanWuseWraloxifene.WWhichWstatementWconcerningWraloxifeneWisWcorre
ct?
A
ItWincreasesWtheWriskWofWbreastWcancer.
B
ItWisWnotWindicatedWforWtreatmentWofWosteoporosis.
C
ItWcanWcauseWdangerousWbloodWclots.
,D
TheWbrandWnameWisWPrezista.
E
ItWreducesWhotWflashesWandWotherWvasomotorWsymptoms.W-
WANSWERWItWcanWcauseWdangerousWbloodWclots.
TheWpharmacistWperformsWaWscreeningWtoWseeWifWJCWrequiresWanyWimmunizations.WWhichWdrugWreferenc
esWwouldWbeWusefulWtoWdetermineWvaccineWrequirementsWforWJC?W(SelectWALLWthatWapply.)
Answer
A
USPW800
B
TheWAmericanWDiabetesWAssociationWStandardsWofWMedicalWCare
C
MorbidityWandWMortalityWWeeklyWReport
D
TheWCDC'sWPinkWBook
E
TheWFDA'sWOrangeWBookW-WANSWERWC
MorbidityWandWMortalityWWeeklyWReport
D
TheWCDC'sWPinkWBook
, WhichWmedicationWincreasesWtheWriskWforWC.WdifficileWinfectionsWandWfracturesWifWusedWlong-term?W
Answer
A
Metoclopramide
B
Naproxen
C
Pantoprazole
D
Fluoxetine
E
SimvastatinW-WANSWERWC
Pantoprazole
TheWpatientWqualifiesWforWaWfentanlyWpatchWbecauseWheWhasWbeenWtakingW____WofWmorphineWequivalent
WdailyWforWatWleastW______.W-WANSWERW60Wmg,W7Wdays
tapentadolWERWbrand?W-WANSWERWNucyntaWER
AWpatientWisWreceivingWribavirinWasWpartWofWherWhepatitisWCWregimen.WWhichWofWtheWfollowingWareWboxe
dWwarningsWforWribavirin?W
Answer
A
TeratogenicWeffectsWandWlacticWacidosis
B
LacticWacidosisWandWhemolyticWanemia